ARTICLE | Company News
FDA accepts Andrx NDA
June 1, 2001 7:00 AM UTC
The FDA accepted for filing ADRX's NDA for Lovastatin XL ( Altocor), an extended-release tablet formulation of lovastatin HMG-CoA reductase inhibitor to prevent cardiovascular disease associated with ...